These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11364292)

  • 1. [[ABC of the antivirals] Project Inform].
    Sidahora; 1996; ():19-32. PubMed ID: 11364292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New drugs for HIV infection.
    Med Lett Drugs Ther; 1996 Apr; 38(972):35-7. PubMed ID: 8606677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Which is the strategy? The latest in the use of antiretrovirals].
    Agosto M
    Sidahora; 1995; ():33-4. PubMed ID: 11363205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ddI and d4T plus protease inhibitors.
    GMHC Treat Issues; 1996 Nov; 10(11):8-9. PubMed ID: 11364012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What we know about anti-HIV drugs.
    Treat Rev; 1995 May; (no 18):3-4. PubMed ID: 11362592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication.
    Perez-Olmeda M; Garcia-Perez J; Mateos E; Spijkers S; Ayerbe MC; Carcas A; Alcami J
    J Med Virol; 2009 Feb; 81(2):211-6. PubMed ID: 19107982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What they say about nucleoside drugs.
    Posit Aware; 1999; 10(1):28-34. PubMed ID: 11366520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No tease this time--pros and cons of a long-awaited anti-HIV drug.
    Chang HE
    Posit Aware; 1996; 7(1):18-20. PubMed ID: 11363118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease inhibitors.
    Treat Rev; 1995; (no 19):2. PubMed ID: 11362753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How far can you knock down HIV? An interview with David D. Ho, MD. Interview by Mark Mascolini.
    Ho DD
    J Int Assoc Physicians AIDS Care; 1997 Jun; 3(6):40-4. PubMed ID: 11364429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV treatment options.
    Smith D
    AIDS Treat News; 1998 May; (No 294):4-5. PubMed ID: 11365404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A patient's guide to protease inhibitors.
    Elperin A; Sax P
    AIDS Clin Care; 1996 Oct; 8(10):83-4. PubMed ID: 11363988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new antiretroviral arsenal.
    Smith D
    AIDS Treat News; 1996 Nov; (No 259):4-5. PubMed ID: 11364001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease inhibitors: implications for HIV research and treatment.
    Churchill SA
    J Int Assoc Physicians AIDS Care; 1996 Jan; 2(1):13-8. PubMed ID: 11363325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zerit vs. Retrovir.
    Posit Aware; 2000; 11(1):25. PubMed ID: 11366345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy for patients with HIV-1 infection: the use of dual nucleoside analogues with protease inhibitors and other agents.
    Gulick R
    AIDS; 1998; 12 Suppl 3():S17-22. PubMed ID: 15168719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple-drug therapy may mean lifelong commitment.
    AIDS Alert; 1999 Jan; 14(1):3-5. PubMed ID: 11366090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The latest antiviral news.
    Vazquez E
    Posit Aware; 1999; 10(2):44. PubMed ID: 11366851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.